Substituted quinoline CCR5 receptor antagonists
US7220856B2 · kind B2 · utility
13Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2003 |
| Grant date | May 22, 2007 |
| Priority date | — |
| Expiry date | Mar 2, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to CCR5 receptor antagonists of formulae (1a) or (1b):enantiomers, diastereomers, salts and solvates thereof wherein R1, R2, R3, R4, R5, and R7 are as defined herein. The invention further includes a method of CCR5-mediated disorders employing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.